14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days £43.00 £57.90 Thursday, 2nd May 2024 AVCT.L stock ended at £46.50. This is 0.535% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.44% from a day low at £45.00 to a day high of £47.00.
90 days £43.00 £110.00
52 weeks £43.00 £166.98

Historical Avacta Group plc prices

Date Open High Low Close Volume
May 02, 2024 £46.00 £47.00 £45.00 £46.50 2 727 374
May 01, 2024 £45.80 £46.75 £44.00 £46.75 2 495 493
Apr 30, 2024 £50.01 £50.98 £45.18 £45.75 5 565 470
Apr 29, 2024 £48.64 £50.25 £48.00 £48.30 3 024 260
Apr 26, 2024 £44.68 £49.40 £44.68 £48.80 5 641 464
Apr 25, 2024 £45.01 £45.50 £44.00 £45.00 2 775 504
Apr 24, 2024 £44.67 £46.00 £43.00 £45.30 4 081 592
Apr 23, 2024 £45.00 £45.80 £43.00 £44.50 4 267 117
Apr 22, 2024 £47.13 £49.00 £43.55 £44.60 6 051 102
Apr 19, 2024 £48.00 £48.50 £45.50 £48.50 2 975 500
Apr 18, 2024 £49.70 £49.70 £47.25 £48.00 2 794 767
Apr 17, 2024 £50.77 £50.77 £49.50 £49.75 1 894 478
Apr 16, 2024 £51.40 £51.70 £50.50 £50.75 1 482 024
Apr 15, 2024 £51.55 £52.10 £50.50 £51.50 1 811 185
Apr 12, 2024 £51.98 £53.00 £51.28 £51.75 1 988 256
Apr 11, 2024 £53.95 £54.50 £52.00 £52.50 1 801 788
Apr 10, 2024 £54.50 £57.90 £53.00 £54.00 4 966 765
Apr 09, 2024 £53.56 £54.00 £51.00 £53.75 2 994 757
Apr 08, 2024 £52.74 £56.00 £52.23 £53.50 9 839 805
Apr 05, 2024 £50.50 £52.85 £49.75 £52.50 4 168 226
Apr 04, 2024 £49.70 £50.90 £49.13 £50.50 2 762 874
Apr 03, 2024 £49.75 £50.25 £48.42 £49.50 2 024 040
Apr 02, 2024 £49.75 £49.75 £49.75 £49.75 0
Mar 28, 2024 £48.94 £50.00 £47.33 £49.75 3 621 715
Mar 27, 2024 £50.97 £51.25 £48.57 £49.00 4 172 279
Click to get the best stock tips daily for free!

About Avacta Group plc

Avacta Group plc Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays. It also develops AffiDX SARS-CoV-2 lateral flow ra... AVCT.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT